Non-invasive Ventilation Masks and Circuits Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
The non-invasive ventilation masks and circuits market has shown promising growth and is expected to continue on this upward trajectory.By 2024, the market is expected to reach $3.85 billion, and by 2031, it is projected to soar to $8.08 billion, reflecting a robust CAGR of 11.20%. By-product non-invasive ventilation masks have dominated the market, holding a significant share in the global market. Non-invasive ventilation masks and circuits also constitute a notable portion of the disposable face masks market.
Sales Analysis and Market Outlook
The non-invasive ventilation (NIV) sector encompasses methods of providing mechanical breathing to the lungs without an invasive artificial airway. Non-invasive ventilation masks and circuits offer physiological and clinical benefits to long-term oxygen therapy patients, reducing hospital admissions and ICU stays, thereby driving market growth. The recent global health crisis has heightened the awareness and preparedness of healthcare facilities, increasing the demand for non-invasive ventilation masks and circuits.
Research and development efforts are pivotal, leading to innovations and modifications in products. Manufacturers are producing ultra-lightweight and affordable non-invasive ventilation masks and circuits suitable for continuous oxygen supply in homecare settings. The rising demand for these products presents lucrative growth opportunities for leading industry players, who are enhancing their market share through acquisitions, partnerships, and collaborations with small and medium manufacturers.
The urgent need for non-invasive ventilation masks and circuits in hospitals worldwide has prompted manufacturers and governments to take drastic measures to develop these products. Non-invasive, low-cost ventilation masks and circuits are expected to simplify weaning times, reduce intubation rates, and lower infection risks, positively impacting adoption rates.
Growth Drivers
The market is anticipated to benefit significantly from the increasing number of people requiring long-term oxygen therapy. Manufacturers are focusing on producing low-cost ventilation masks and circuits to meet the needs of patients in home healthcare settings. The rising prevalence of chronic respiratory diseases necessitates continuous demand for medications and non-invasive ventilation solutions.
Healthcare providers recommend continued oxygen therapy for chronic obstructive pulmonary disease (COPD) patients, improving their emotional and cognitive functions. Although non-invasive ventilation masks and circuits enhance functional performance and manage leaks, they are currently prescribed for a substantial portion of stable COPD patients in many European countries. Collaborations and new product developments by companies are contributing to the global growth of the non-invasive ventilation masks and circuits market.
Challenges
Despite the promising growth, the market faces challenges due to the high cost of non-invasive ventilation masks and circuits. Emerging and developing countries struggle to afford these advanced medical products due to limited healthcare funding. The market expansion may be hindered if hospitals in low- and middle-income nations cannot afford the necessary equipment. Additionally, production capacity limitations and inadequate availability of appropriate products to address growing cases could impede market growth.
Regional Insights
United States: The U.S. market for non-invasive ventilation masks and circuits is booming, driven by increased healthcare spending and improvements in healthcare infrastructure. The adoption of modern equipment in home care settings and hospitals is rising due to their efficiency and affordability. Government initiatives to enhance medical spending and healthcare infrastructure are further supporting market growth in the U.S.
Germany: Germany is a lucrative market for non-invasive ventilation masks and circuits, propelled by technological advancements, a large patient population, and a high prevalence of respiratory ailments. The growing aging population, increased R&D spending, and technological improvements in respiratory devices contribute to market expansion in Germany.
China: China is emerging as a prominent market due to the high prevalence of respiratory dysfunctions and COPD. The significant pool of COPD patients often requires breathing support, increasing the demand for non-invasive ventilation masks and circuits. Efforts towards early detection of COPD in China are expected to boost market growth.
Product and Application Insights
Product: Non-invasive ventilation masks dominate the product segment, driven by their ability to enable breathing without intubation or surgical airways. These masks are used with pulmonary alveolar proteinosis PAP devices for managing acute and chronic respiratory conditions. The growing demand for non-invasive ventilation therapy without the need for tracheotomy or intubation supports the global demand for these masks.
Application: Respiratory dysfunction applications hold a significant share in the global market. The rising prevalence of respiratory failures and increased availability and use of non-invasive ventilation masks and circuits drive market growth. The procedural benefits of these products for treating respiratory illnesses further enhance their demand.
End User: Hospitals are the primary end users, holding a substantial share of the global market. Manufacturers are collaborating with hospitals and ambulatory surgical centers for direct sales, equipment maintenance, and staff training to increase the utilization of non-invasive ventilation masks and circuits. Emerging market players are integrating with limited firms in developing countries, offering growth opportunities for manufacturers.
Competitive Analysis
Manufacturers are focused on developing new products and enhancing existing ones to improve patient outcomes. Consistent growth strategies include offering a wider selection of cutting-edge medical devices and new technologies. Active collaborations and market expansions are key to increasing market share globally.
Key Developments:
• Cardinal Health completed the acquisition of Mirixa Corporation, a provider of medication therapy management services.
• Magnolia Medical Technologies collaborated with Cardinal Health to improve patient safety and healthcare costs.
• Koninklijke Philips N.V. achieved the milestone of selling 10 million DreamWear Continuous Positive Airway Pressure (CPAP) masks.
Key Companies
• Hamilton Medical, Inc.
• Fisher & Paykel Healthcare Limited.
• Air Liquid Medical Systems
• Koninkliijke Philips N.V.
• ResMed Inc.
• Dragerwerk AG & Co. KGaA
• Armstrong Medical
• Cardinal Health Inc.
• Well Lead Medical Co Ltd
• Vyaire Medical
• Intersurgical
Segments Covered
Product:
• Non-invasive Ventilation Circuits
• Non-invasive Ventilation Masks (Disposable and Reusable)
Application:
• Anesthesia
• Respiratory Dysfunction
• COPD
• Pneumonia
• Others
End User:
• Hospitals
• Ambulatory Surgery Centers
• Critical Care
• Neonatal Intensive Care
• Homecare Settings
Regions:
• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa
Please note: Delivery Timelines - 5 working days.